T80.810A

The ICD-10-CM code for extravasation of vesicant antineoplastic chemotherapy, init is T80.810A. The full clinical description is "Extravasation of vesicant antineoplastic chemotherapy, initial encounter". T80.810A is a billable/specific code that can be used on insurance claims and medical billing.

ICD-10-CM code T80.810A represents “Extravasation of vesicant antineoplastic chemotherapy, initial encounter”. It is classified under Chapter 19: Injury, Poisoning and Certain Other Consequences of External Causes and is a billable/specific code that can be used on a claim.

Yes, T80.810A is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.

T80.810A is in Chapter 19: Injury, Poisoning and Certain Other Consequences of External Causes (codes S00-T88).

T80.810A is linked to 1 UMLS Concept Unique Identifier: C2886821. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.

ICF (International Classification of Functioning, Disability and Health) codes describe how conditions like extravasation of vesicant antineoplastic chemotherapy, init affect a person's functioning: body functions, activities, participation, and environmental factors. AutoICD provides ICF Core Sets for 12+ conditions and can map clinical text to ICF categories automatically. Browse the ICF directory to explore functioning codes.

There is no direct ICD-11 mapping available for T80.810A in the WHO crosswalk tables. This may mean the concept is classified differently in ICD-11. Use the ICD-10 to ICD-11 converter to search for related codes.